Partner at Novo Holdings · Joined 2018
View Live Interactive Profile →João Ribas joined Novo Holdings Seed Investments in 2018, focusing on early-stage investments and venture creation, and is listed on the firm's people page as a Partner. Novo Holdings says he holds several board positions and has led investments in Asgard Therapeutics, Tribune Therapeutics and Orbis Medicines, and that he often combines his investment role with interim operational responsibilities in portfolio companies. Before Novo Holdings he was a Fellow at M Ventures, the corporate venture capital arm of Merck KGaA, and earlier founded new ventures in the United States and Europe. He earned his PhD from the University of Coimbra, conducting research at Harvard Medical School and Brigham and Women's Hospital. Novo Holdings press releases in January and March 2025 describe him as Principal rather than Partner.